Ergomed Plc
Industry Group: Pharmaceuticals
Country/Region: United Kingdom
Identifier: -
Ergomed PLC is engaged in the healthcare sector. Its business involves the provision of drug development services to the pharmaceutical industry. The company operates through two segments: Clinical Research Services and Pharmacovigilance. It provides clinical development services to clients ranging from top 10 pharmaceutical companies to small and mid-sized drug development companies. The PV segment has expertise in the field of pharmacovigilance and provides medical information services.
ESG Risk Rating
Ranking
Industry Group (1st = lowest risk)
Pharmaceuticals 57 out of 921
Universe
Global Universe 3407 out of 16216
What are the ESG Risk Ratings?
Notice: The information is provided as is, for informational, non-commercial purposes only, does not constitute investment advice and is subject to conditions available in our Legal Disclaimer. They are not directed to, or intended for distribution to or use by India-based clients or users and their distribution to Indian resident individuals or entities is not permitted. Usage of this information is not permitted in any way, unless otherwise agreed in writing. By way of exception, usage of this information is permitted to the rated subject, limited to a single reference to the score on the rated subject’s sustainability webpage or CSR report, mentioning Sustainalytics as a source. For referencing Sustainalytics please consult the Company Guide.
Industry Comparison
Company | ESG Risk Rating | Industry Rank |
---|---|---|
Syneos Health, Inc. |
17.3
Low
|
53 out of 921 |
Ergomed Plc |
17.7
Low
|
57 out of 921 |
CMIC Holdings Co., Ltd. |
22.4
Medium
|
144 out of 921 |
For corporate professionals interested in direct competitor insights
Sustainalytics' Peer Performance Insights gives an in-depth analysis of your company's ESG strengths and weaknesses compared to your competitors and industry performance. These insights can be used to identify areas of ESG improvement to help inform future management decisions that align with your organization's sustainability goals.
Our Approach to Calculating ESG Risk
The ESG Risk Ratings measure a company's exposure to industry-specific material ESG risks and how well a company is managing those risks.
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues. Our exposure score takes into consideration subindustry and company-specific factors such as its business model.
Ergomed Plc's Exposure is Low
Management
Management refers to how well a company is managing its relevant ESG issues. Our management score assesses the robustness of a company's ESG programs, practices and policies.
Ergomed Plc's Management of ESG Material Risk is Average